Soleno Therapeutics Prices $200 Mln Public Offering To Support VYKAT XR Launch
10/7 16:20
(RTTNews) - Soleno Therapeutics (SLNO), Thursday announced the pricing of its underwritten public offering of approximately 2.35 million shares of common stock at $85.00 per share, expected to raise about $200 million in gross proceeds....